论文部分内容阅读
目的探讨舒利迭治疗支气管哮喘的临床疗效及其在应用中的不良反应。方法将我院2010年6月-2011年6月收治的94例支气管哮喘患者随机分为对照组和治疗组,对照组采用喘康速气雾剂吸入治疗,治疗组采用舒利迭吸入治疗,比较两组患者的治疗效果。结果治疗组:临床控制21(44.68%),显效15(31.91%),好转9(19.15%),无效2(4.26%),总有效率95.74%;对照组:临床控制9(19.15%),显效10(21.28%),好转14(29.79%),无效14(29.79%),总有效率70.21%,两组患者间进行比较,p<0.05,差异性显著,差异有统计学意义。两组患者均未出现明显的不良反应。结论舒利迭治疗支气管哮喘治疗方法比较简便,可以有效地控制患者的病情,大大地改善患者的肺功能,而且其治疗安全可靠,无严重的不良反应,值得临床推广和应用。
Objective To investigate the clinical efficacy of seretide in the treatment of bronchial asthma and its adverse reactions in the application. Methods A total of 94 patients with bronchial asthma admitted to our hospital from June 2010 to June 2011 were randomly divided into control group and treatment group. Control group was treated with inhaled aerosol aerosol inhalation. The treatment group was treated with sulpiride inhalation, The treatment effect of two groups of patients was compared. Results In the treatment group, the clinical control was 21 (44.68%), the effective rate was 15 (31.91%), the improvement was 9 (19.15%), the effective rate was 2 (4.26%), the total effective rate was 95.74% The effective rate was 10 (21.28%), 14 (29.79%) were improved, 14 (29.79%) were ineffective, and the total effective rate was 70.21%. There was significant difference between two groups of patients with p <0.05, the difference was statistically significant. No significant adverse reactions occurred in both groups. Conclusion Seretide treatment of bronchial asthma treatment is relatively simple, can effectively control the patient’s condition, greatly improve the patient’s lung function, and its safe and reliable treatment, no serious adverse reactions, is worthy of clinical promotion and application.